Table 1

 Individual pathological, clinical, MRI, and PET-MET data

Patient noClinical dataMRI dataPET-MET dataPathological data
SexAgeAge at epilepsy onset (years)Epilepsy duration (years)LocationSideGadolinium enhancementTumour size (best diameter) in mmVisual methionine uptakeMean T/CMax T/CORCamera
DNT, dysembryoplastic neuroepithelial tumour; F, female; Fr, frontal; I, insula; L, left; Lt, lateral temporal; M, male; max T/C, maximal tumour-to-contralateral homotopic ratio; mean T/C, mean tumor-to-contralateral homotopic ratio; MET-PET, [11C]-methionine positron emission tomography; mT, mesial temporal; MRI, magnetic resonance imaging; NA, not available; O, occipital; OR, tumour-to-contralateral occipital ratio; P, parietal; R, right.
1M24213lTR+26Normal0.951.150.94TTVDNT
2F24195lTR+32Marked1.952.71.89TTVPleomorphic Xanthoastrocytoma II
3M32257I + Fr + PR+54MarkedNA5.82.7TTVOligodendroglioma III
4F18135mTL+20NormalNANANATTVDNT
5M311417mTL13Normal0.630.660.44TTVDNT
6F463412Fr + TR53MarkedNA3.631.86TTVOligodendroglioma III
7M221012mTR30NormalNANANATTVDNT
8M56506O + lTL62Marked1.532.931.62TTVOligodendroglioma III
9F13103mTR+28Moderate1.251.760.85TTVGanglioglioma
10M23320OLNA35MarkedNA2.251.14TTVGanglioglioma
11M19172.5FrL + R+33Marked1.781.91.83TTVPilocytic Astrocytoma I
12M12102mTR+22Moderate1.742.21.1HR+Ganglioglioma
13F42375mTL25Normal1.041.30.88HR+DNT
14F1073O + lTL35Moderate0.911.71.05HR+DNT
15F16214mTR+19Moderate2.042.331.35HR+Ganglioglioma
16F44143O + lTR28Moderate1.301.761.16HR+Ganglioglioma
17F817T + FrL62ModerateNA1.640.85HR+Oligodendroglioma II
18M402515FrR51Marked1.703.372.35HR+Oligodendroglioma II
19F46306PL43Moderate1.221.71.07HR+DNT
20M321814mTL31Normal1.171.070.81HR+DNT
21F27251.5lTLNA27ModerateNA1.881.19HR+DNT
22M43421.5mTR32Marked1.423.111.9HR+Astrocytoma III
23M26268 monthsI + Fr + TR69Moderate1.282.91.31HR+Oligoastrocytoma II
24F18810lT + mTL29Moderate1.061.71.2HR+DNT
25M42339FrR38Moderate1.662.011.23HR+Oligoastrocytoma II
26M27189mTL+22Normal1.241.190.65HR+DNT
27M41356O + lTL+48Marked2.273.372.32HR+Oligodendroglioma II